Ware J. Anthony 4

4 · First Tracks Biotherapeutics, Inc. · Filed May 14, 2026

AI-generated summary of this filing

Updated May 15, 2026

First Tracks (TRAX) Director Ware J. Anthony Receives 57,000-Share Award

What Happened

Director Ware J. Anthony was granted two derivative awards on May 12, 2026: 15,000 restricted stock units (RSUs) and an award of options covering 42,000 shares (57,000 total). Both grants were reported with $0.00 acquisition price (typical for RSU/option grants). These were awards/grants (A) rather than open‑market purchases or sales.

Key Details

Transaction date: 2026-05-12; Form 4 filed: 2026-05-14 (timely filing).
Grant amounts and reported prices: 15,000 RSUs @ $0.00; 42,000 options/derivative award @ $0.00.
Shares owned after the transaction: not specified in the provided filing excerpt.
Notable footnotes from the filing:
- F1: Each RSU represents a contingent right to receive 1 share upon settlement for no consideration.
- F2: The RSUs vest 100% on the date of the Issuer’s 2027 annual meeting, subject to continued service.
- F3: The stock option vests 1/12 monthly beginning June 12, 2026, subject to continued service.
- F4: In addition to the 42,000-option grant, the reporting person holds additional options to purchase up to 131,585 shares that vest per their own terms.
Filing timeliness: The Form 4 was filed within the normal reporting window (no late filing indicated).

Context

RSUs are a contingent right to receive shares at settlement and do not involve an immediate cash purchase; they typically convert to shares when vested and settled.
The 42,000 award appears to be options that vest over time (monthly installments), not an immediate exercise or sale; exercise price is not specified in the provided details.
Awards/grants are common for compensation and retention and do not by themselves indicate buying/selling sentiment.

Form 4

Period: 2026-05-12

Director

Transactions

Award
Restricted Stock Unit
[F1][F2]
2026-05-12+15,000→ 15,000 total
→ Common Stock (15,000 underlying)
Award
Stock Option (right to buy)
[F3][F4]
2026-05-12+42,000→ 42,000 total
Exercise: $17.81Exp: 2036-05-11→ Common Stock (42,000 underlying)

Footnotes (4)

[F1]Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.
[F2]The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2027 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
[F3]The stock option vests as to 1/12 of the total shares monthly commencing on June 12, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
[F4]In addition to the options to purchase a total of 42,000 shares of common stock as set forth in Table II, the Reporting Person also holds additional options to purchase up to an aggregate of 131,585 shares of common stock, which options vest according to their terms.

Signature

/s/ Ajim Tamboli, Attorney-in-Fact|2026-05-14

1 file